Please use this identifier to cite or link to this item:
metadata.artigo.dc.title: Host–guest complexation of a nitroheterocyclic compound with cyclodextrins: a spectrofluorimetric and molecular modeling study
metadata.artigo.dc.creator: Grillo, Renato
Melo, Nathalie F. S. de
Araújo, Daniele R. de
Trossini, Gustavo H. G.
Cunha, Elaine F. F. da
Ramalho, Teodorico de Castro
Fraceto, Leonardo Fernandes
metadata.artigo.dc.subject: Nitroheterocyclic compound
Fluorescence spectroscopy
Molecular modeling
Inclusion complex
Composto nitro-heterocíclico
Espectroscopia de fluorescência
Modelagem molecular
metadata.artigo.dc.publisher: Springer Apr-2010
metadata.artigo.dc.identifier.citation: GRILLO, R. et al. Host–guest complexation of a nitroheterocyclic compound with cyclodextrins: a spectrofluorimetric and molecular modeling study. Journal of Inclusion Phenomena and Macrocyclic Chemistry, Dordrecht, v. 66, n. 3-4, p. 417-421, Apr. 2010.
metadata.artigo.dc.description.abstract: Nitroheterocyclic compounds (NC) were candidate drugs proposed for Chagas disease chemotherapy. In this study, we investigated the complexation of hydroxymethylnitrofurazone (NFOH), a potential antichagasic compound, with α-cyclodextrin (α-CD), β-cyclodextrin (β-CD), Hydroxypropyl-β-cyclodextrin (HP-β-CD), Dimethyl-β-cyclodextrin (DM-β-CD) and γ-cyclodextrin (γ-CD) by fluorescence spectroscopy and molecular modeling studies. Hildebrand–Benesi equation was used to calculate the formation constants of NFOH with cyclodextrins based on the fluorescence differences in the CDs solution. The complexing capacity of NFOH with different CDs was compared through the results of association constant according to the following order: DM-β-CD > β-CD > α-CD > HP-β-CD > γ-CD. Molecular modeling studies give support for the experimental assignments, in favor of the formation of an inclusion complex between cyclodextrins with NFOH. This is an important study to investigate the effects of different kinds of cyclodextrins on the inclusion complex formation with NFOH and to better characterize a potential formulations to be used as therapeutic options for the oral treatment of Chagas disease.
metadata.artigo.dc.language: en_US
Appears in Collections:DQI - Artigos publicados em periódicos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.